Electrolytic transdermal delivery of polypeptides

作者: Dan Sibalis , Sanford Rosen

DOI:

关键词:

摘要: The invention comprises in combination: (a) a polypeptide having from about three to 20 peptide units aqueous solution or suspension, and (b) an electrolytic device for transdermal transport of the bloodstream patient. It may be useful enhance delivery by adding cosolute/cosolvent with negative Setschenow constants. preferably hydrophilic reservoir containing supply electric battery, two extended contacts, optionally semipermeable membrane between patient's skin. Representative polypeptides include oxytocin, angiotensin I, II, III, substance P, vasopressin, lypressin, desmopressin, leuprolide acetate, antripeptin, like.

参考文章(31)
Elie S. Nuwayser, Method of transdermal drug delivery ,(1984)
Jorge Heller, Wilfred A. Skinner, Kenichiro Saito, Susumu Satoh, Method for percutaneously administering physiologically active agents ,(1985)
Richard D. Luntz, Stephen C. Jacobsen, Ion mobility limiting iontophoretic bioelectrode ,(1981)
Robert L. Stephen, Tomasz J. Petelenz, Stephen C. Jacobsen, Methods and apparatus for iontophoresis application of medicaments ,(1986)
Richard Luntz, David Knutti, Robert L. Stephen, R. Todd Johnson, Stephen C. Jacobsen, Epidermal iontophoresis device ,(1976)